Tama Evron

1.3k total citations
19 papers, 1.0k citations indexed

About

Tama Evron is a scholar working on Molecular Biology, Pharmacology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Tama Evron has authored 19 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 9 papers in Pharmacology and 5 papers in Cellular and Molecular Neuroscience. Recurrent topics in Tama Evron's work include Cholinesterase and Neurodegenerative Diseases (8 papers), Receptor Mechanisms and Signaling (6 papers) and Neuropeptides and Animal Physiology (3 papers). Tama Evron is often cited by papers focused on Cholinesterase and Neurodegenerative Diseases (8 papers), Receptor Mechanisms and Signaling (6 papers) and Neuropeptides and Animal Physiology (3 papers). Tama Evron collaborates with scholars based in United States, Israel and Germany. Tama Evron's co-authors include Marc G. Caron, Hermona Soreq, Tanya L. Daigle, Bryan L. Roth, Nikhil M. Urs, Talma Brenner, Shlomo Seidman, Neli Boneva, Huixian Wu and Gye Won Han and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Tama Evron

19 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tama Evron United States 16 675 257 218 109 98 19 1.0k
Yongmei Pu United States 16 704 1.0× 151 0.6× 89 0.4× 43 0.4× 134 1.4× 22 1.0k
Gretchen Gibney United States 14 543 0.8× 246 1.0× 394 1.8× 257 2.4× 55 0.6× 18 1.1k
Tomáš Dobránsky Canada 21 766 1.1× 453 1.8× 119 0.5× 36 0.3× 249 2.5× 30 1.2k
Joan M. Lyles United Kingdom 17 541 0.8× 246 1.0× 289 1.3× 135 1.2× 136 1.4× 20 1.0k
J. Mark Treherne United Kingdom 18 607 0.9× 546 2.1× 94 0.4× 80 0.7× 55 0.6× 43 1.3k
Ming‐Shiu Hung Taiwan 21 508 0.8× 177 0.7× 217 1.0× 29 0.3× 44 0.4× 36 1.2k
Wenfeng Yu China 22 716 1.1× 281 1.1× 206 0.9× 37 0.3× 75 0.8× 65 1.4k
Wayne Chadwick United States 19 510 0.8× 310 1.2× 52 0.2× 61 0.6× 39 0.4× 31 1.0k
Renza Roncarati Italy 22 813 1.2× 262 1.0× 113 0.5× 30 0.3× 118 1.2× 31 1.1k
Nathalie Duval France 16 719 1.1× 139 0.5× 475 2.2× 306 2.8× 71 0.7× 19 1.2k

Countries citing papers authored by Tama Evron

Since Specialization
Citations

This map shows the geographic impact of Tama Evron's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tama Evron with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tama Evron more than expected).

Fields of papers citing papers by Tama Evron

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tama Evron. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tama Evron. The network helps show where Tama Evron may publish in the future.

Co-authorship network of co-authors of Tama Evron

This figure shows the co-authorship network connecting the top 25 collaborators of Tama Evron. A scholar is included among the top collaborators of Tama Evron based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tama Evron. Tama Evron is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Evron, Tama, Laura Boffa, Nicola Biagio Mercuri, et al.. (2021). Potent T cell‐mediated anti‐inflammatory role of the selective CB2 agonist lenabasum in multiple sclerosis. Neuropathology and Applied Neurobiology. 48(2). e12768–e12768. 17 indexed citations
2.
Tarique, Abdullah A., Tama Evron, George Zhang, et al.. (2020). Anti-inflammatory effects of lenabasum, a cannabinoid receptor type 2 agonist, on macrophages from cystic fibrosis. Journal of Cystic Fibrosis. 19(5). 823–829. 15 indexed citations
3.
Huang, Xi‐Ping, Marc G. Caron, Raymond C. Stevens, et al.. (2020). Structural basis for Smoothened receptor modulation and chemoresistance to anticancer drugs. UNC Libraries. 1 indexed citations
4.
Bruni, Giancarlo N., Andrew J. Rennekamp, Matthew N. McCarroll, et al.. (2016). Zebrafish behavioral profiling identifies multitarget antipsychotic-like compounds. Nature Chemical Biology. 12(7). 559–566. 111 indexed citations
5.
Urs, Nikhil M., Steven M. Gee, Thomas F. Pack, et al.. (2016). Distinct cortical and striatal actions of a β-arrestin–biased dopamine D2 receptor ligand reveal unique antipsychotic-like properties. Proceedings of the National Academy of Sciences. 113(50). E8178–E8186. 107 indexed citations
6.
Barak, Larry S., Yushi Bai, Sean M. Peterson, et al.. (2016). ML314: A Biased Neurotensin Receptor Ligand for Methamphetamine Abuse. ACS Chemical Biology. 11(7). 1880–1890. 37 indexed citations
7.
Wang, Chong, Huixian Wu, Tama Evron, et al.. (2014). Structural basis for Smoothened receptor modulation and chemoresistance to anticancer drugs. Nature Communications. 5(1). 4355–4355. 200 indexed citations
8.
Evron, Tama, Sean M. Peterson, Nikhil M. Urs, et al.. (2014). G Protein and β-Arrestin Signaling Bias at the Ghrelin Receptor. Journal of Biological Chemistry. 289(48). 33442–33455. 60 indexed citations
9.
Philipp, Melanie, Tama Evron, & Marc G. Caron. (2013). The Role of Arrestins in Development. Progress in molecular biology and translational science. 118. 225–242. 11 indexed citations
10.
Evron, Tama, Tanya L. Daigle, & Marc G. Caron. (2012). GRK2: multiple roles beyond G protein-coupled receptor desensitization. Trends in Pharmacological Sciences. 33(3). 154–164. 125 indexed citations
11.
Evron, Tama, Melanie Philipp, Jiuyi Lü, et al.. (2011). Growth Arrest Specific 8 (Gas8) and G Protein-coupled Receptor Kinase 2 (GRK2) Cooperate in the Control of Smoothened Signaling. Journal of Biological Chemistry. 286(31). 27676–27686. 25 indexed citations
12.
Ofek, Keren, Karen S. Krabbe, Tama Evron, et al.. (2007). Cholinergic status modulations in human volunteers under acute inflammation. Journal of Molecular Medicine. 85(11). 1239–1251. 86 indexed citations
13.
Evron, Tama, Brian C. Geyer, Irene Cherni, et al.. (2007). Plant‐derived human acetylcholinesterase‐R provides protection from lethal organophosphate poisoning and its chronic aftermath. The FASEB Journal. 21(11). 2961–2969. 28 indexed citations
14.
Zemel, Esther, Nicolás Cuenca, Tama Evron, et al.. (2007). A Novel Isoform of Acetylcholinesterase Exacerbates Photoreceptors Death after Photic Stress. Investigative Ophthalmology & Visual Science. 48(3). 1290–1290. 20 indexed citations
15.
Evron, Tama, David Greenberg, Tsafrir S. Mor, & Hermona Soreq. (2006). Adaptive changes in acetylcholinesterase gene expression as mediators of recovery from chemical and biological insults. Toxicology. 233(1-3). 97–107. 23 indexed citations
16.
Evron, Tama, et al.. (2005). RNA-Targeted Suppression of Stress-Induced Allostasis in Primate Spinal Cord Neurons. Neurodegenerative Diseases. 2(1). 16–27. 21 indexed citations
17.
Geyer, Brian C., et al.. (2005). Purification of transgenic plant-derived recombinant human acetylcholinesterase-R. Chemico-Biological Interactions. 157-158. 331–334. 24 indexed citations
18.
Geyer, Brian C., et al.. (2004). Tissue distribution of cholinesterases and anticholinesterases in native and transgenic tomato plants. Plant Molecular Biology. 55(1). 33–43. 11 indexed citations
19.
Brenner, Talma, et al.. (2003). The role of readthrough acetylcholinesterase in the pathophysiology of myasthenia gravis. The FASEB Journal. 17(2). 214–222. 95 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026